Showing results (361-370 of 375) with videos related to
Sort By:
Pageof 38
Multiple Sclerosis and Related Disorders|April 23, 2022
Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple SclerosisTamara B Kaplan, Arpita Gopal, Valerie J Block, et al.Yearbook of Medical Informatics|April 8, 2025
Social Determinants of Health in Digital Health Policies: an International Environmental ScanJiyoun Song, Mollie Hobensack, Lydia Sequeira, et al.JMIR Human Factors|January 11, 2024
A Closed-Loop Falls Monitoring and Prevention App for Multiple Sclerosis Clinical Practice: Human-Centered Design of the Multiple Sclerosis Falls InsightTrackValerie J Block, Kanishka Koshal, Jaeleene Wijangco, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2022
Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosisValerie J Block, Shuiting Cheng, Jeremy Juwono, et al.Plos One|January 27, 2025
Distinguishing benign and malignant myxoid soft tissue tumors: Performance of radiomics vs. radiologistsJoshua M Lawrenz, Can Cui, Samuel R Johnson, et al.Journal of Neurology|November 30, 2016
Continuous daily assessment of multiple sclerosis disability using remote step count monitoringV J Block, A Lizée, E Crabtree-Hartman, et al.International Journal of Medical Informatics|July 6, 2026
Integrating diversity, equity, and inclusion in generative AI applications for healthcare education: a scoping reviewHwayeon Danielle Shin, Charlene E Ronquillo, Jisan Lee, et al.Healthcare Informatics Research|February 15, 2024
Technological Challenges and Solutions in Emergency Remote Teaching for Nursing: An International Cross-Sectional SurveyEunjoo Jeon, Laura-Maria Peltonen, Lorraine J Block, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2015
Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven yearsDaniel J Lovell, Nicolino Ruperto, Richard Mouy, et al.Lancet (London, England)|July 18, 2008
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trialNicolino Ruperto, Daniel J Lovell, Pierre Quartier, et al.Pageof 38